Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women

Calcified Tissue International

Volumn 66, Issue 3, 2000, Pages 190-194

  Miyao, M ^a   Morita, H ^a   Hosoi, T ^b   Kurihara, H ^a   Inoue, S ^a   Hoshino, S ^a   Shiraki, M ^c   Yazaki, Y ^a   Ouchi, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Tokyo Metropolitan Institute of Gerontology   (Japan)

^c RESEARCH INSTITUTE AND PRACTICE FOR INVOLUTIONAL DISEASES   (Japan)

Author keywords

Bone mineral density; Genetic risk factor; Homocysteine; Methylenetetrahydrofolate reductase; Osteoporosis

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN EXPERIMENT; HYPERHOMOCYSTEINEMIA; JAPAN; LUMBAR SPINE; NORMAL HUMAN; OSTEOPOROSIS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

AGED; AGED, 80 AND OVER; AMINO ACIDS; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BONE DENSITY; FEMALE; GENOTYPE; HUMANS; JAPAN; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OSTEOCALCIN; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMORPHISM, GENETIC; POSTMENOPAUSE;

EID: 0033953774     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002230010038     Document Type: Article

References (36)

1. Consensus Development conference (1993) Diagnosis prophylactics and treatment of osteoporosis. Am J Med 94:646-650
2. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM (1993) Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 341:962-963
3. Seeman E, Hopper JL, Bach LA, Cooper ME, Parkinson E, McKay J, Jerums G (1989) Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 320:554-558
4. Tylavsky FA, Bortz AD, Hancock RL, Anderson JJ (1989) Familial resemblance of radial bone mass between premenopausal mothers and their college-age daughters. Calcif Tissue Int 45:265-272
5. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl S (1987) Genetic determinants of bone mass in adults: a twin study. J Clin Invest 80:706-710
6. Kelly PJ, Nguyen T, Hopper J, Pocock N, Sambrook P, Eisman J (1993) Changes in axial bone density with age: a twin study. J Bone Miner Res 8:11-17
7. Hoper JL, Green RM, Nowson CA, Young D, Sherwin AJ, Kaymakci B, Larkins RG, Wark JD (1998) Genetic, common environment, and individual specific components of variance for bone mineral density in 10-to 26-year-old females: a twin study. Am J Epidemiol 147:17-29
8. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA (1994) Prediction of bone density from Vitamin D receptor alleles. Nature 367:284-287
9. Melhus H, Kindmark A, Amer S, Wilen B, Lindh E, Ljunghall S (1994) Vitamin D receptor genotypes in osteoporosis. Lancet 344:949-950
10. Cooper GS, Umbach DM (1997) Are vitamin D receptor polymorphisms associated with bone mineral density? A meta-analysis. J Bone Miner Res 11:1841-1849
11. Sainz J, Van Tornout JM, Lor ML, Sayre J, Roe TF, Gilsanz (1997) Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med 337:77-82
12. Sano M, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H (1995) Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378-383
13. Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H (1996) Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11: 306-311
14. Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y (1997) Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12:1438-1445
15. Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF (1997) A sequence variation: 713-8 delC in transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20:289-294
16. Greenfield EM, Goldberg VM (1997) Genetic determination of bone density. Lancet 350:1263-1264
17. Nelson DA, Kleerekoper M (1997) The search for the osteoporosis gene. J Clin Endocrinol Metab 82:989-990
18. Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH (1996) Reduced bone density and osteoporosis associated with a polymorphic SpI binding site in the collagen type I a 1 gene. Nat Genet 14:203-205
19. Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FEA, Grant SFA, Hofman A, Johannes PTM, Leeuwen, Pols HAP, Ralston SA (1998) Relation of alleles of the collagen type I a 1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338:1016-1021
20. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R, Fowler B, Groebe H, Schmidt H, Schweitzer L (1985) The natural history of homocystinuria due to cystathionine betasynthase deficiency. Am J Hum Genet 37:1-31
21. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050
22. Kang SS, Wong PW, Susmano A, Sora J, Norusis M, Ruggie N (1991) Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 48:536-545
23. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
24. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y (1997) Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95:2032-2036
25. Morita H, Kurihara H, Tsubaki S, Sugiyama T, Hamada C, Kurihara Y, Shindo T, Oh-hashi Y, Kitamura K, Yazaki Y (1998) Methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and ischemic stroke in Japanese. Arterioscler Thromb Vasc Biol 18:1465-1469
26. Kang AH, Trelstad RL (1973) A collagen defect in homocystinuria. J Clin Invest 52:2571-2578
27. Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA, Thomas CM, Eskes TK (1995) Plasma homocysteine and menopausal status. Eurø J Clin Invest 25:801-805
28. Schmitz C, Lindpaintner K, Verhonef P, Gaziano JM, Buring ScD (1996) Genetic polymorphism of methylentetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation 94:1812-1814
29. Orimo H, Sugioka Y, Fukunaga M, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, Oh-hashi Y (1998) Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 16:139-150
30. Whiting SJ, Draper HH (1981) Effect of a chronic acid load as sulfate or sulfur amino acids on bone metabolism in adult rats. J Nutr 111:1721-1726
31. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GHJ (1996) Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1315:159-162
32. Sillence D (1981) Osteogenesis imperfecta: an expanding panorama of variants. Clin Orthop 159:11-25
33. Knott L, Bailey J (1998) A collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone 22:181-187
34. van der Mooren MJ, Wouters MG, Blom HJ, Schellekens LA, Eskes TK, Rolland R (1994) Hormone replacement therapy may reduce high serum homocysteine in postmenopausal women. Eurø J Clin Invest 24:733-736
35. Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J (1995) Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet 346:85-89
36. Guttormsen AB, Ueland PM, Nesthus I, Nygard O, Schneede J, Vollset SE, Refsum H (1996) Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (>40 μmol/liter). The Hordaland Homocysteine Study. J Clin Invest 98:2174-2183